NRC Health's Q2 earnings per share rise year over year on higher recurring contract value and strong Governance Institute bookings, partly offset by elevated operating expenses.
NRC Health (NRC) Q2 2026 Earnings Call Transcript
National Research NASDAQ: NRC, operating as NRC Health, reported second-quarter results marked by 11% year-over-year growth in total recurring contract value, while management said investments in implementation, customer success and product development supported a large customer deployment and future growth initiatives.
| Health Care Equipment & Supplies Industry | Healthcare Sector | Trent Green CEO | XFRA Exchange | 637372202 CUSIP |
| US Country | 357 Employees | 25 Sep 2026 Last Dividend | - Last Split | 10 Oct 1997 IPO Date |
Founded in 1981 and based in Lincoln, Nebraska, National Research Corporation is a leader in delivering comprehensive analytics and insights designed to enhance both patient and employee experiences within the healthcare sector. The company's offerings span across critical areas such as patient experience, service recovery, care transitions, and employee engagement, among others. Its mission is to provide healthcare organizations with actionable information and analysis that support improvement initiatives, reputation management, and brand loyalty efforts. National Research Corporation's solutions cater to a wide array of needs, aligning with the goals of maximizing constituent satisfaction and organizational effectiveness in healthcare settings.
National Research Corporation's suite of products and services is meticulously crafted to address various facets of healthcare organization needs, with a focus on delivering actionable insights for improvement and strategic management. Key offerings include: